Abstract
Here we report the synthesis of boron nitride nanotubes (BNNTs) via a chemical vapor deposition method, as potential agents for boron neutron capture therapy. BNNTs were functionalized with PAMAM[G-2] dendrimer and then, conjugated with l-Phe using EDC/NHS. After that, BNNTs were radiolabeled with 125/131I, which are commonly used for both therapy and diagnosis in clinical and pre-clinical studies. BNNTs were radiolabeled with a maximum yield with 125/131I in compared with 4-borono-l-phenyalanine which is currently used as a commercial drug. Radiolabeling parameters were optimized with thin layer radiochromatography and high performance liquid radiochromatography. BNNTs are promising nanobioconjugates as new theranostic agents.
Similar content being viewed by others
References
Chen XY, Gambhir SS, Cheon J (2011) Theranostic nanomedicine. Acc Chem Res 44(10):841
Jokerst JV, Gambhir SS (2011) Molecular imaging with theranostic nanoparticles. Acc Chem Res 44(10):1050–1060
Bhojani MS, Van Dort M, Rehemtulla A, Ross BD (2010) Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol Pharm 7(6):1921–1929
Chen X, Wu P, Rousseas M, Okawa D, Gartner Z, Zettl A, Bertozzi CR (2009) Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J Am Chem Soc 131:890–891
Zhang WS, Zheng JG, Li WF, Geng DY, Zhang ZD (2009) Synthesize and characterization of hollow boron-nitride nanocages. J Nanomater. doi:10.1155/2009/264026
Zhi C, Bando Y, Tan C, Golberg D (2005) Effective precursor for high yield synthesis of pure BN nanotubes. Solid State Commun 135:67–70
Oku T, Hiraga K, Matsuda T, Hirai T, Hirabayashi M (2003) Formation and structures of multiply-twinned nanoparticles with fivefold symmetry in chemical vapor deposited boron nitride. Diam Relat Mater 12:1918–1926
Tang C, Bando Y, Sato T, Kurashima K (2002) A novel precursor for synthesis of pure boron nitride nanotubes. Chem Commun 30(12):1290–1291
Cheng L, Hu Q, Cheng L, Hu W, Xu M, Zhu Y, Zhang L, Chen D (2015) Construction and evaluation of PAMAM–DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release properties. Colloids Surf B 136:37–45
Jain K, Kesharwani P, Gupta U, Jain NK (2010) Dendrimer toxicity: let’s meet the challenge. Int J Pharm 394:122–142
Hossain SU, Kambhampati SP, Mishra MK, Lesniak WG, Zhang F, Kannan RM (2013) Enhancing the efficacy of Ara–C through conjugation with PAMAM dendrimer and linear PEG: a comparative study. Biomacromolecules 14:801–810
Shukla S, Wu G, Chatterjee M, Yang W, Sekido M, Diop LA, Muller R, Sudimack JJ, Lee RJ, Barth RF, Tjarks W (2003) Synthesis and biological evaluation of folate receptor-targeted boronated PAMAM dendrimers as potential agents for neutron capture therapy. Bioconjug Chem 14:158–167
Barth RF, Coderre JA, Graça Vicente MH, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11:3987–4002
Chen X, Wu P, Rousseas M, Okawa D, Gartner Z, Zettl A, Bertozz CR (2009) Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J Am Chem Soc 131:890–891
Heister E, Neves V, Tilmaciu C, Lipert K, Sanz Beltran V, Coley HM, Silva SRP, McFadden J (2009) Triple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapy. Carbon 47:2152–2160
Ozdemir D, Unak P (1994) Study on labeling conditions of I-125 synkavit by the iodogen method. J Radioanal Nucl Chem Lett 187(4):277–283
Akin M, Bongartz R, Walter JG, Odaci Demirkol D, Stahl F, Timur S, Scheper T (2012) PAMAM-functionalized water soluble quantum dots for cancer cell targeting. J Mater Chem 22(23):11529–11536
Unak T, Akgun Z, Yıldırım Y, Duman Y, Erenel G (2001) Self-iodination of iodogen. Appl Radiat Isot 54(5):749–752
Medine IE, Unak P, Sakarya S, Toksoz F (2010) Enzymatic synthesis of uracil glucuronide, labeling with 125/131I and in vitro evaluation on adenocarcinoma cells. Cancer Biother Radiopharm 25(3):335–344
Tekin V, Biber Muftuler FZ, Kozgus Guldu O, Yurt Kilcar A, Medine EI, Yavuz M, Unak P, Timur S (2014) Biological affinity evaluation of Lawsonia inermis origin Lawsone compound and its radioiodinated form via in vitro methods. J Radioanal Nucl Chem 303(1):701–707
Zhi C, Bando Y, Tan C, Golberg D (2005) Effective precursor for high yield synthesis of pure BN nanotubes. Solid State Commun 13(5):67–70
Xie SY, Wang W, Shiral Fernando KA, Wang X, Lin Y, Sun YP (2005) Solubilization of boron nitride nanotubes. Chem Commun. doi:10.1039/B505330G
Mills WJ, Sutton CH, Baize MW, Todd LJ (1991) Boron analogues of valine, leucine, isoleucine, and phenylalanine: syntheses of amine-alkyl (N ethylcarbamoyl) boranes. Inorg Chem 30:1046–1052
Wang J, Lee CH, Bando Y, Golberg D, Yap YK (2009) Multiwalled boron nitride nanotubes: growth, properties, and applications. In: Yap YK (ed) B-C-N nanotubes and related nanostructures. Springer, New York, pp 23–44
Pecce R, Scolamiero E, Ingenito L, Parenti G, Ruoppolo M (2013) Optimization of an HPLC method for phenylalanine and tyrosine quantization in dried blood spot. Clin Biochem 46:1892–1895
Yu J, Qin L, Hao Y, Kuang S, Bai X, Chong YM, Zhang W, Wang E (2010) Vertically aligned boron nitride nanosheets: chemical vapor synthesis, ultraviolet light emission, and superhydrophobicity. ACS Nano 4(1):414–422
Teraoa T, Bandoa Y, Mitome M, Kurashima K, Zhi CY, Tang CC, Golberg D (2008) Effective synthesis of surface-modified boron nitride nanotubes and related nanostructures and their hydrogen uptake. Physica E 40:2551–2555
Wang XZ, Wu Q, Hu Z, Chen Y (2007) Template-directed synthesis of boron nitride nanotube arrays by microwave plasma chemical reaction. Electrochim Acta 52:2841–2844
Guo L, Singh RN (2009) Catalytic growth of boron nitride nanotubes using gas precursors. Physica E 41:448–453
Dischino DD, Welch MJ, Kilbourn MA, Raichie ME (1983) Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med 24:1030–1038
Liu B, Qi W, Tian L, Li Z, Miao G, An W, Liu D, Lin J, Zhang X, Wu W (2015) In vivo biodistribution and toxicity of highly soluble PEG-coated boron nitride in mice. Nanoscale Res Lett 10:478–484
Unak P, Cetinkaya B (2005) Absorbed dose estimates at the cellular level for (131)I. Appl Radiat Isot 62(6):861–869
Braghirolli AMS, Waissmann W, da Silva JB (2014) Production of iodine-124 and its applications in nuclear medicine. Appl Radiat Isot 90:138–148
Genadya AR, Nakamura H (2010) Undecahydro-closo-dodecaborates as good leaving groups in organic synthesis: generation of substituted styrenes via elimination of arylethyl dodecaborates. Org Biomol Chem 8:4427–4435
Barth RF, Vicente MGH, Harling OK, Kiger WS, Riley KJ, Binns PJ, Wagner FM, Suzuki M, Aihara T, Kato I, Kawabata S (2012) Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer. Radiat Oncol 7:146
El-Sayed M, Ginski M, Rhodes C, Ghandehari H (2002) Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 81(3):355–365
El-Sayed M, Ginski M, Rhodes C, Ghandehari H (2003) Influence of surface chemistry of poly(amidoamine) dendrimers on caco-2 cell monolayers. J Bioact Compat Polym 18(1):7–22
Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D’Emanuele A (2003) The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 252:263–266
Kitchens KM, El-Sayed MEH, Ghandehari H (2005) Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev 57(15):2163–2176
Kolhatkar RB, Kitchens KM, Swaan PW, Ghandehari H (2007) Surface acetylation of polyamidoamine (PAMAM) dendrimers decreases cytotoxicity while maintaining membrane permeability. Bioconjug Chem 18(6):2054–2060
Saovapakhiran A, D’Emanuele A, Attwood D, Penny J (2009) Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization. Bioconjug Chem 20(4):693–701
Acknowledgements
The authors thank to the Ege University Scientific Research Fund for the financial support through the project number 2015 NBE 002. Associate Professor Arzu Turkler Ege and Associate Professor Mehmet Ayvacikli from Celal Bayar University are acknowledged for their valuable helps during the synthesis step of BNNTs. Dr Hasan Demiroglu from Celal Bayar University is acknowledged for his helps during FTIR measurements.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Guldu, O.K., Unak, P. & Timur, S. A novel theranostic nanobioconjugate: 125/131I labeled phenylalanine conjugated boron nitride nanotubes. J Radioanal Nucl Chem 311, 1751–1762 (2017). https://doi.org/10.1007/s10967-016-5127-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-016-5127-4